Additional information received from reporter on 3/25/2022 for report mw5107279; a 2022 report from ecri described a potential hazard where bd - 50 ml syringes may contain debris.According to the report, multiple pharmacy technicians have noticed the debris, but lot numbers were not recorded.This information was shared with pharmacy compounding personnel at healthcare.On "x/x/2022," pharmacy personnel at hospital of central (a healthcare facility) noticed debris in a bo - 10 ml syringe upon drawing up a medication.The debris was not seen in the vial prior to withdrawing, was seen in the syringe, and it was seen in the prepared final product which was then discarded.Wrapper and syringe were not saved.This information was shared across healthcare.This was reported to bd and fda medwatch.On "x/x/2022", pharmacy personnel at medical center (a healthcare facility) noticed debris in a bd 18 g 1 ½ in needle hub.The needle was not used for medication preparation.The syringe and over wrapper was saved.Product name: bo precisionglide needle 18g x 1 ½ ref 305196, lot 1120195.This information was shared across healthcare.This was reported to bo and fda medwatch.Communication related to the possibility of debris in sterile product equipment increased awareness and staff diligence prevented use of equipment with debris for the compounding of sterile medication.Circumstances or events have capacity to cause error.(b)(6).
|